Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
In this guide, you'll learn what BPC-157 actually is and how it works specifically in foot tissue, which conditions respond best (and which don't), how it fits inside a complete treatment plan, and how to access it safely through a physician rather than a supplement website
Why are BPC-157 and TB-500 often discussed together
The only way to know for sure is to discuss your symptoms with a medical professional who can help you connect the dots and determine if B12 injections are a good path for you
AOD-9604 Injection Guide Subcutaneous (SubQ) injection see our peptide injection guide is the standard for aod 9604 protocol administration
